Read on
Corbion announced today that Marcel Wubbolts will join as Chief Technology Officer, effective 1 November 2016.
Editorial office / Amsterdam

As Chief Technology Officer, Marcel will be responsible for Corbion’s global R&D organization. He will be driving the innovation and technology agenda enabling business development opportunities to support the company’s growth journey. Marcel will be part of Corbion’s Executive Committee.

Marcel Wubbolts holds a Ph.D. in Mathematics and Natural Sciences from the University of Groningen. Following several positions in academia, he joined DSM, a global science-based company active in health, nutrition and materials based in the Netherlands. Currently, Marcel is CTO and member of the DSM global leadership team. During his 20 years of service at DSM he held several science leadership positions in biochemistry and biotechnology, aiming at developing sustainable production methods for intermediates for pharma, nutritional and materials applications. In addition, he is well connected in the broader biotechnology industry network, amongst others he chairs the Governing Board of the Biobased Industries Joint Undertaking, a Public-Private Partnership between the EU and the Biobased Industries Consortium. Marcel Wubbolts is a Dutch national.

Tjerk de Ruiter, CEO Corbion: “Our commitment to innovation is deeply embedded in our strategy and culture, our global R&D team works every day on turning science into innovations that meet our customer needs. We are very happy to welcome Marcel to Corbion and we believe his extensive experience, passion and keen eye for scientifically relevant applications, make him well suited to lead Corbion’s R&D organization and drive our innovation agenda to an even higher level.”